Cargando…
Therapeutic dendritic cell vaccine preparation using tumor RNA transfection: A promising approach for the treatment of prostate cancer
BACKGROUND: Early prostate adenocarcinoma can be diagnosed through seric prostate-specific antigen (PSA) screenings. However, a fraction of patients progress to an incurable metastatic disease. Therefore, novel therapies for treating these patients are extremely desirable. Therapeutic vaccines based...
Autores principales: | Sousa-Canavez, Juliana M, Canavez, Flavio C, Leite, Kátia RM, Camara-Lopes, Luiz H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259348/ https://www.ncbi.nlm.nih.gov/pubmed/18205933 http://dx.doi.org/10.1186/1479-0556-6-2 |
Ejemplares similares
-
Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer
por: dos Reis, Sabrina Thalita, et al.
Publicado: (2011) -
Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells—An Update
por: Dörrie, Jan, et al.
Publicado: (2020) -
DNA Vaccination: Transfection and Activation of Dendritic Cells as Key Events for Immunity
por: Akbari, Omid, et al.
Publicado: (1999) -
Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
por: Vik-Mo, Einar Osland, et al.
Publicado: (2013) -
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
por: Mu, L J, et al.
Publicado: (2005)